Lane Simonian
Contributor since: 2015
Latest Articles
Alzheimer's Pathways: An Investor's Guide To Biogen, Anavex, And Neurotrope
Biogen: One More Time Around The Alzheimer's Block
Biogen Results: Time To Change The Paradigm In Alzheimer's Disease
Biogen And Alzheimer's Disease: Reasons For Caution
Alzheimer's Disease: A History Of Drug Failures
Anavex 2-73: Addressing The Causes Of Alzheimer's Disease
Neurotrope And The Missing Step In Alzheimer's Disease
Anavex 2-73 And The Stabilization Of Alzheimer's Disease
Biogen, Neurotrope, Anavex And The Future Of Alzheimer's Treatments
Anavex And Alzheimer's Disease At The Crossroads
The Curious Case Of Neurotrope
Alzheimer's Disease: Anavex 2-73 And The Long Road Home
Why The Anti-Amyloid Approach To Alzheimer's Disease Has Failed
Alzheimer's Disease: A Case For Combination Therapy
Alzheimer's Disease: 40 Years In The Wilderness
Neurotrope: Lessons Learned
Alzheimer's Disease: What's Next?
Can Anything Be Learned From Alzheimer's Drug Failures?
Alzheimer's Disease: A Year Behind; A Year Ahead
Anavex 2-73: The Right Path To The Treatment Of Alzheimer's Disease?
Alzheimer's Disease: A Tale Of 2 Trials
Why It's Not All About That BACE
The Last Hurrah For The Amyloid Hypothesis Of Alzheimer's Disease?
Anavex 2-73: Making Sense Of The Data
Anavex 2-73: Hints Of Success
Anavex 2-73: While We Wait
Anavex 2-73: Making The Science Clearer
Anavex 2-73: How It May Work
Anavex: An Alternative Hypothesis